LUNG
PulmonxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LUNG Profile
Pulmonx Corporation
A global leader in minimally invasive treatments for severe lung disease
Healthcare Equipment and Supplies
--
10/01/2020
NASDAQ Stock Exchange
291
12-31
Common stock
700 Chesapeake Drive, Redwood City, California 94063
--
Pulmonx Corporation was re-incorporated in December 2013 under the laws of the State of Delaware. Pulmonx Corporation is a commercial-grade medical technology company that provides minimally invasive treatment for patients with severe emphysema, a chronic obstructive pulmonary disease. Currently, the company's products are available in 25 countries, and as of December 31, 2019, more than 76,000 valves were used to treat more than 19,000 patients. Among them, the Zephyr valve has been included in the global chronic obstructive pulmonary disease treatment guidelines.
